CVRX Stock Analysis: Buy, Sell, or Hold?
CVRX - CVRx, Inc. Common Stock
$6.11
0.04 (0.66%)
▲
5d:
+2.0%
30d:
-20.03%
90d:
-10.01%
BUY
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When CVRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CVRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CVRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CVRX is currently trading at $6.11, which is considered slightly low relative to its 30-day fair value range of $6.07 to $7.73.
Technical Outlook: Technically, CVRX is showing sideways momentum. Immediate support is located at $5.00, while resistance sits at $7.23.
Market Sentiment: CVRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.17 (+82.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CVRX is showing sideways momentum. Immediate support is located at $5.00, while resistance sits at $7.23.
Market Sentiment: CVRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.17 (+82.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.07 -
$7.73
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 82.8% below Wall St target ($11.17)
Trading Range Analysis
30-Day Trading Range
$6.07 -
$7.73
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.97
(15.8%)
Support & Resistance Levels
Support Level
$5.00
Resistance Level
$7.23
Current Trend
Sideways
Technical data as of
May 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.23
Wall Street Target
$11.17
(+82.8%)
Revenue Growth (YoY)
19.6%
Profit Margin
-89.1%
Share & Embed Analysis
Last updated: May 25, 2026 5:21 AM ET
Data refreshes hourly during market hours. Next update: 6:21 AM
Data refreshes hourly during market hours. Next update: 6:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVRX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Philip B Adamson
SELL
1262 shares
2026-03-02
Mudit K Jain
BUY
46800 shares
2026-02-20
Mudit K Jain
BUY
600 shares
2026-02-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 67 BUY |
Advanced CVRX Option Strategies
Professional options setups generated by AI based on today's CVRX price and gamma walls.
